Netherlands Ophthalmic Surgical Devices Market is expected to grow with the CAGR of 1.5% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/zh/reports/netherlands-ophthalmic-surgical-devices-market
Netherlands ophthalmic surgical devices market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Netherlands ophthalmic surgical devices market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.
For instance,
- In November 2020, Carl Zeiss AG announced in their website that the company will participate in 124th annual meeting of the American Academy of Ophthalmology held virtually. The company provided various opportunities such as direct vender interactions and thereby strengthening their global position in market.
Carl Zeiss AG is dominating player in Netherlands ophthalmic surgical devices market. The other key players existing in the market includes Alcon Inc., Johnson & Johnson Services, Inc., Bausch & Lomb Incorporated, HASA OPTIX, Eurocrystal, STAAR SURGICAL, Ophtec BV, Takagi Ophthalmic Instruments Europe Ltd, BVI, TELEON, Simovision BV, De Ceunynck Medical NV, EyeD Pharma, and NEWLEAF OPHTHALMOLOGY BV among others.
Carl Zeiss AG
Carl Zeiss AG is headquartered in Jena, Germany and was founded in year 2002. The company is engaged in enabling healthcare professionals worldwide to improve the lives of their patients in ophthalmology, microsurgery and other medical growth sectors. The company offers product categories such as ophthalmology and microsurgery, out of which ophthalmology is the market focused category.
For instance,
- In November 2020, Carl Zeiss AG announced in their website that the company will participate in 124th annual meeting of the American Academy of Ophthalmology held virtually. The company provided various opportunities such as direct vender interactions and thereby strengthening their global position in market.
The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, and Middle East and Africa with its various subsidiaries such as Cart Zeiss Meditec (Guangzhou) Ltd (China), Carl Zeiss Meditec Iberia S.A (Spain), Carl Zeiss Meditech Xo. Ltd (Japan), and Carl Zeiss Meditech, Inc. (U.S.) among others.
Alcon Inc.
Alcon Inc. is headquartered in Geneva, Switzerland and was founded in 1945. The company is engaged in research, development, manufacturing and distribution of products and solutions for eye care including surgical and vision care products. The company offers various products like ocular health, refractive technology, cataract surgery, and vitreoretinal surgery where all are market focused categories.
For instance,
- In March 2020, Alcon Inc. announced that it has launched the AcrySof IQ Vivity, an intraocular lens for presbyopia treatment in the European market. The launch of this product has increased the sales in the Europe market.
The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, and Middle East and Africa with its various subsidiaries such as Alcon (China) Ophthalmic Product Co., Ltd. (China), Alcon Japan Ltd. (Japan), Alcon Pharmaceuticals Ltd. (Switcerland), Alcon Finance Corporation (U.S.) and Alcon Research, LLC (U.S.) among others.
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. is headquartered in New Jersey, U.S. and was founded in 1887. The company is engaged in the research and development, manufacturing and sale of the broad range of products in the health care field. The company offers various products like consumer health products, medical devices, and pharmaceutical products where the market focused category is medical devices.
For instance,
- In February 2021, Johnson & Johnson Services, Inc. announced that it has received the U.S. FDA approval for its TECNIS Eyhance and TECNIS Eyhance Toric II intraocular lens (IOL) used for the cataract patients in the U.S. This approval received by the company has increased its credibility and demand in the market.
The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, and Middle East and Africa with its various subsidiaries such as Acclarent, Inc. (U.S.), Ethicon Endo-Surgery, Inc. (U.S.), Actelion Pharmaceuticals Japan Ltd. (Japan), AMO Belgium BVBA (Belgium) and AMO Germany GmbH (Germany) among others.
